Literature DB >> 15622497

[Conservative and surgical treatment of neurotrophic keratopathy].

B Seitz1, M Grüterich, C Cursiefen, F E Kruse.   

Abstract

Neurotrophic keratopathy is one of the most challenging conditions among the disorders of wound healing of the ocular surface. In addition to bilateral assessment of corneal sensitivity, tear status and lid function must be analyzed and treated by unpreserved artificial tears and adequate lid surgery. Further conservative treatment options include hyaluronic acid and dexpanthenol as well as autologous serum. Application of recombinant growth factors (especially NGF) represents an interesting perspective. Concerning surgical interventions, temporary or permanent occlusion of the lacrimal punctum may be accompanied by lateral tarsorrhaphy which is easy to perform, potentially reversible, and in most cases successful. Depending on the type of wound healing disorder amniotic membrane transplantation may be helpful either as basal membrane transplant (graft) or as a patch, or in combination (sandwich). A tectonic keratoplasty a chaud should typically be combined with a simultaneous amniotic membrane patch and/or a lateral tarsorrhaphy to avoid persistent epithelial defects.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15622497     DOI: 10.1007/s00347-004-1161-7

Source DB:  PubMed          Journal:  Ophthalmologe        ISSN: 0941-293X            Impact factor:   1.059


  43 in total

Review 1.  Neurotrophic keratitis.

Authors:  E A Davis; C H Dohlman
Journal:  Int Ophthalmol Clin       Date:  2001

Review 2.  Neurotrophic keratitis.

Authors:  S Bonini; P Rama; D Olzi; A Lambiase
Journal:  Eye (Lond)       Date:  2003-11       Impact factor: 3.775

3.  Corneal sensitivity and burning sensation. Comparing topical ketorolac and diclofenac.

Authors:  B Seitz; K Sorken; L D LaBree; J J Garbus; P J McDonnell
Journal:  Arch Ophthalmol       Date:  1996-08

4.  Topical treatment with nerve growth factor for corneal neurotrophic ulcers.

Authors:  A Lambiase; P Rama; S Bonini; G Caprioglio; L Aloe
Journal:  N Engl J Med       Date:  1998-04-23       Impact factor: 91.245

Review 5.  Management of neurotrophic keratopathy.

Authors:  A Lambiase; P Rama; L Aloe; S Bonini
Journal:  Curr Opin Ophthalmol       Date:  1999-08       Impact factor: 3.761

6.  Single and multilayer amniotic membrane transplantation for persistent corneal epithelial defect with and without stromal thinning and perforation.

Authors:  P Prabhasawat; N Tesavibul; W Komolsuradej
Journal:  Br J Ophthalmol       Date:  2001-12       Impact factor: 4.638

7.  Amniotic membrane transplantation for persistent epithelial defects with ulceration.

Authors:  S H Lee; S C Tseng
Journal:  Am J Ophthalmol       Date:  1997-03       Impact factor: 5.258

8.  Topical treatment with nerve growth factor for neurotrophic keratitis.

Authors:  S Bonini; A Lambiase; P Rama; G Caprioglio; L Aloe
Journal:  Ophthalmology       Date:  2000-07       Impact factor: 12.079

9.  The role of NGF signaling in human limbal epithelium expanded by amniotic membrane culture.

Authors:  Amel Touhami; Martin Grueterich; Scheffer C G Tseng
Journal:  Invest Ophthalmol Vis Sci       Date:  2002-04       Impact factor: 4.799

10.  Conjunctival flaps.

Authors:  A M Alino; H D Perry; A J Kanellopoulos; E D Donnenfeld; E K Rahn
Journal:  Ophthalmology       Date:  1998-06       Impact factor: 12.079

View more
  12 in total

1.  [Chemical and thermal eye burns. Conservatíve and surgical options of a stage-dependent therapy].

Authors:  H G Struck; N F Schrage
Journal:  Ophthalmologe       Date:  2011-10       Impact factor: 1.059

Review 2.  [Surgery of large and persistent macular holes].

Authors:  Christos Haritoglou; Armin Wolf; Joachim Wachtlin
Journal:  Ophthalmologe       Date:  2019-11       Impact factor: 1.059

3.  [Diagnosis of dry eye disease].

Authors:  C Jacobi; E M Messmer
Journal:  Ophthalmologe       Date:  2018-05       Impact factor: 1.059

Review 4.  [Current treatment for dry eye syndrome].

Authors:  C Cursiefen; C Jacobi; T Dietrich; F E Kruse
Journal:  Ophthalmologe       Date:  2006-01       Impact factor: 1.059

Review 5.  [Albumin eye drops for treatment of ocular surface diseases].

Authors:  J D Unterlauft; M Kohlhaas; I Hofbauer; K Kasper; G Geerling
Journal:  Ophthalmologe       Date:  2009-10       Impact factor: 1.059

6.  [Botulinum toxin A induced protective ptosis for the treatment of recurrent epithelial defects in neurotrophic keratopathy].

Authors:  A Schilimow; B Wiechens
Journal:  Ophthalmologe       Date:  2017-08       Impact factor: 1.059

7.  ["Herpetic keratitis". Various expressions require different therapeutic approaches].

Authors:  B Seitz; A Heiligenhaus
Journal:  Ophthalmologe       Date:  2011-04       Impact factor: 1.059

Review 8.  [Ophthalmological complications in Sjögren's syndrome].

Authors:  C Jacobi; C Cursiefen
Journal:  Z Rheumatol       Date:  2010-02       Impact factor: 1.372

Review 9.  [Current and experimental treatment approaches for neurotrophic keratopathy].

Authors:  J Alder; S Mertsch; J Menzel-Severing; G Geerling
Journal:  Ophthalmologe       Date:  2019-02       Impact factor: 1.059

10.  [Defect covering of a perforated corneal ulcer with bovine pericardium transplant].

Authors:  J Kroll; R-L Merté; N Eter
Journal:  Ophthalmologe       Date:  2014-01       Impact factor: 1.059

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.